Astrogliosis in an Experimental Model of Hypovitaminosis B12: A Cellular Basis of Neurological Disorders due to Cobalamin Deficiency.
Zuzanna RzepkaJakub RokJustyna KowalskaKlaudia BanachJustyna Magdalena HermanowiczArtur BeberokBeata SiekluckaDorota GrykoDorota WrześniokPublished in: Cells (2020)
Cobalamin deficiency affects human physiology with sequelae ranging from mild fatigue to severe neuropsychiatric abnormalities. The cellular and molecular aspects of the nervous system disorders associated with hypovitaminosis B12 remain largely unknown. Growing evidence indicates that astrogliosis is an underlying component of a wide range of neuropathologies. Previously, we developed an in vitro model of cobalamin deficiency in normal human astrocytes (NHA) by culturing the cells with c-lactam of hydroxycobalamin (c-lactam OH-Cbl). We revealed a non-apoptotic activation of caspases (3/7, 8, 9) in cobalamin-deficient NHA, which may suggest astrogliosis. The aim of the current study was to experimentally verify this hypothesis. We indicated an increase in the cellular expression of two astrogliosis markers: glial fibrillary acidic protein and vimentin in cobalamin-deficient NHA using Western blot analysis and immunocytochemistry with confocal laser scanning microscopy. In the next step of the study, we revealed c-lactam OH-Cbl as a potential non-toxic vitamin B12 antagonist in an in vivo model using zebrafish embryos. We believe that the presented results will contribute to a better understanding of the cellular mechanism underlying neurologic pathology due to cobalamin deficiency and will serve as a foundation for further studies.
Keyphrases
- endothelial cells
- replacement therapy
- high resolution
- induced apoptosis
- poor prognosis
- gram negative
- single molecule
- signaling pathway
- pluripotent stem cells
- south africa
- mass spectrometry
- spinal cord
- high throughput
- cell proliferation
- binding protein
- risk assessment
- early onset
- physical activity
- depressive symptoms
- blood brain barrier
- small molecule
- climate change
- neuropathic pain
- cerebral ischemia